TITLE

Fluconazole Mucoadhesive Buccal Films: In Vitro/In Vivo Performance

AUTHOR(S)
Yehia, Soad A.; El-Gazayerly, Omaima N.; Basalious, Emad B.
PUB. DATE
January 2009
SOURCE
Current Drug Delivery;Jan2009, Vol. 6 Issue 1, p17
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Fluconazole mucoadhesive buccal films were prepared using film forming polymers namely; hydroxypropyl methyl cellulose (HPMC), hydroxyethyl cellulose (HEC), chitosan, Eudragit and sodium alginate (SALG) either alone or in combination with bioadhesive polymers. The bioadhesive polymers studied were sodium carboxymethyl cellulose (SCMC), Carbopol 974P, and polycarbophil (AA-A). The prepared films were characterized by means of film thickness, surface pH, swelling capacity, in vitro adhesion, in vivo residence time, in vitro drug release and in vivo drug release to determine the amount of drug release from selected film formulae using microbiological assay and HPLC. Optimum release behavior, convenient bioadhesion, acceptable elasticity were exhibited by film containing 2% HPMC and 1% SCMC (fresh or stored for 6 months). Determination of the amount of drug released in saliva after application of the selected fluconazole films confirmed the ability of the film to deliver the drug over a period of approximately 300 minutes and to reduce side effects and possibility of drug interaction encountered during systemic therapy of fluconazole, which would be beneficial in the case of oral candidiasis.
ACCESSION #
37365497

 

Related Articles

  • Development and Evaluation of Buccal adhesive Fluconazole Tablets. Kushwaha, Sudhir; Sharma, Pramod Kumar; Bansal, Mayank // Asian Journal of Pharmaceutical & Biological Research (AJPBR);Jun2011, Vol. 1 Issue 2, p195 

    Objective: The purpose of this work was to evaluate the effect of formulation variables on release properties and bio adhesive strength in development of Fluconazole bucc al adhesive tablets. Methods:Formulations were prepared based on variable ratio of different polymers. The dependent...

  • Development and Evaluation of Buccal adhesive Fluconazole Tablets. Kushwaha, Sudhir; Sharma, Pramod Kumar; Bansal, Mayank // Asian Journal of Pharmaceutical & Clinical Research;Apr2011, Vol. 1 Issue 2, p195 

    Objective: The purpose of this work was to evaluate the effect of formulation variables on release properties and bio adhesive strength in development of Fluconazole bucc al adhesive tablets. Methods:Formulations were prepared based on variable ratio of different polymers. The dependent...

  • Geographic Tongue. Masferrer, Emili; Jucgla, Anna // New England Journal of Medicine;11/12/2009, Vol. 361 Issue 20, pe44 

    The article deals with a case of a 61-year-old man who was referred for a painless white lesions treatment on his tongue. It states that the patient was treated with systemic and topical antifungal drugs for oral candidiasis, however, the lesions were unchanged after the medical therapy. It...

  • Pseudomembranous candidosis in nephrotic syndrome: A case report. Prusinski, Leo; Sherman, Robert G.; Ravenel, Michele Carter; Joralmon, Richard A. // Quintessence International;Jul/Aug2002, Vol. 33 Issue 7, p533 

    A 33-year-old male presented for evaluation of several large, recently discovered white oral lesions of unknown duration. Clinical examination revealed multiple white plaques on the soft palate, uvula, buccal mucosa, and tongue. These lesions could be wiped away, leaving an erythematous base....

  • Oral candidiasis in Human Immunodeficiency Virus (HIV) infected individuals in Iran. Katiraee, Farzad; Khosravi, Ali Reza; Khalaj, Vahid; Hajiabdolbaghi, Mahboubeh; Khaksar, Ali Asghar; Rasoulinejad, Mehrnaz; Nejad, Mir Saeed Yekani // Tehran University Medical Journal;Apr2010, Vol. 68 Issue 1, p37 

    Background: Oropharyngeal candidiasis is the most frequent fungal infection in HIV patients. The aims of this study were to appraise prevalence of oropharyngeal candidiasis and to determine factors associated with oropharyngeal candidiasis and oral yeast colonization among Iranian HIV patients....

  • In vitro antifungal susceptibility of Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus in Ethiopia. Wabe, Nasir Tajure; Hussein, Jemal; Suleman, Sultan; Abdella, Kedir // Journal of Experimental & Integrative Medicine;2011, Vol. 1 Issue 4, p265 

    Objective: Oral Candidiasis is the most common HIV related oral lesion. Most patients are infected with a strain originally present as a commensal of the oral cavity. The chronic use of antifungal agents, in the treatment of candidiasis mainly in HIV/AIDS patients leads to the selection of...

  • Formulation and Evaluation of in situ Gels Containing Clotrimazole for Oral Candidiasis. HARISH, N. M.; PRABHU, P.; CHARYULU, R. N.; GULZAR, M. A.; SUBRAHMANYAM, E. V. S. // Indian Journal of Pharmaceutical Sciences;2009, Vol. 71 Issue 4, p421 

    Gel dosage forms are successfully used as drug delivery systems to control drug release and protect the medicaments from a hostile environment. The main objective is to formulate and evaluate in situ oral topical gels of clotrimazole based on the concept of pH triggered and ion activated...

  • ORAL CANDIDAL INFECTIONS AND ANTIMYCOTICS. Ellepola, A. N. B.; Samaranayake, L. P. // Critical Reviews in Oral Biology & Medicine;2000, Vol. 11 Issue 2, p172 

    The advent of the human immunodeficiency virus infection and the increasing prevalence of compromised individuals in the community due to modern therapeutic advances have resulted in a resurgence of opportunistic infections, including oral candidoses. One form of the latter presents classically...

  • Evaluating the Sensitivity of Candida Albicans Isolates from Oral Candidiasis of AIDS Patients to Fluconazole by Microdilution Broth and Disk Diffusion Methods. Armaki, Mojtaba Taghizadeh; Farahbakhsh, Ehsan; Yadegari, Mohammad Hossein; Bazl, Masoumeh Rajabi; Katiraee, Farzad // Journal of Isfahan Medical School;12/12/2011, Vol. 29 Issue 158, p1 

    Background: Candida albicans is a pathogenic yeast that causes oral, vaginal and systemic infections. Oral candidiasis is treated with antifungal agents, particularly triazoles such as fluconazole. However, the overuse of fluconazole has resulted in the emergence of azole-resistant strains of...

Share

Read the Article

Courtesy of your local library

Public Libraries Near You (See All)
Looking for a Different Library?

Other Topics